• Home
  • Biopharmaceutical Research Services
  • Multi-Omics Services
  • Support
  • /assets/images/icon/icon-email-2.png

    Email:

    info@MtoZ-Biolabs.com

    End-Group Analysis of Protein

      End-group analysis of protein is a technique in proteomics research primarily used to determine the amino acid sequences at both termini of protein molecules. Typically, protein ends include the N-terminus (amino terminus) and the C-terminus (carboxyl terminus). This analysis not only provides structural information but also elucidates various biological functions. For example, the N-terminus is closely linked to signal peptide recognition, protein localization, and cellular half-life, while the C-terminus is often involved in protein stability, interactions with other molecules, and functional regulation. End-group analysis of protein is valuable in many research fields, including protein identification, discovery of novel proteins, and studies of protein function. By performing end-group analysis, researchers can obtain precise structural data that are critical for new drug development, early disease diagnosis, and biomarker discovery. Moreover, this technique is essential for understanding post-translational modifications, proteolytic cleavage, and degradation processes. In the biopharmaceutical arena, specific terminal modifications may influence the stability and activity of therapeutic proteins; thus, detailed analysis of protein end groups facilitates the design and optimization of these biologics.

       

      End-group analysis of protein can address limitations inherent in traditional protein sequencing methods, particularly when dealing with complex protein mixtures. High-efficiency techniques enable rapid and accurate identification and quantification of proteins across diverse samples, a capability that is crucial for high-throughput proteomics research. In clinical investigations, end-group analysis can also be applied to study various pathological conditions, such as cancer, cardiovascular, and metabolic diseases, by identifying disease-associated terminal modifications or truncated forms, thereby aiding in the discovery of potential therapeutic targets and biomarkers. The high accuracy and sensitivity of this approach render it an indispensable tool in modern biological research.

       

      A variety of methods are available for end-group analysis of protein, including chemical derivatization, enzymatic cleavage, and mass spectrometry. Among these, mass spectrometry is widely utilized due to its high sensitivity and resolution. It can rapidly identify and quantify protein terminal sequences without the need for extensive protein separation. When coupled with liquid chromatography, mass spectrometry can analyze even more complex samples, greatly enhancing the throughput and precision of end-group analysis. Chemical derivatization and enzymatic cleavage are typically employed in conventional studies of protein labeling and modifications; the former uses specific reagents to react with protein termini for easier detection, while the latter employs selective enzymes to cleave terminal amino acids, thereby facilitating sequence determination.

       

      MtoZ Biolabs offers high-quality protein analysis services. Our team of experienced scientists provides customized solutions tailored to the specific needs of our clients. We are dedicated to delivering state-of-the-art technology and reliable data to support scientific discoveries and innovative applications in proteomics research.

       

      MtoZ Biolabs, an integrated chromatography and mass spectrometry (MS) services provider.

      Related Services

    Submit Inquiry
    Name *
    Email Address *
    Phone Number
    Inquiry Project
    Project Description *

     

    How to order?


    /assets/images/icon/icon-message.png

    Submit Inquiry

    /assets/images/icon/icon-return.png